Current market trends and future projections for orphan drugs
Novel strategies for formulating and delivering orphan drug therapies
Recent case studies and real-world evidence in patient advocacy
Tech-driven innovation and advances in rare disease therapy development
Health equity and patient perspectives in orphan drug management
Regulatory and policy shifts in the ecosystem of rare disease therapeutics